Aptatek Biosciences

medical devices

About

Aptatek is developing cutting edge technologies for portable disease management devices that will improve patient compliance, wellness, and overall quality of life. To start, they are focusing on Phenylketonuria (PKU), a disease where patients must closely monitor their phenylalanine levels for their entire lifetimes or face severe health challenges. Currently, PKU patients have no choice but to visit a hospital or mail in blood samples to a central lab. Aptatek's proprietary aptamer design strategies and patented sequences create the opportunity for novel tests and new test strategies. The core technology was developed in the laboratories of Dr. Milan Stojanovic and Dr. Tilla Worgall, faculty members at Columbia University Medical Center. It is based on DNA aptamer sequences that detect small molecule biomarkers which cannot be detected by antibodies. The sensitivity and specificity matches laboratory instruments including mass spectrometry. Learn more at https://aptatek.com/

Technologies

Gmail Google Apps Amazon AWS Mobile Friendly Remote

Keywords

real-time blood testing medical devices portable handheld device robust sensor design medication management tools healthcare technology home health diagnostics clinical diagnostics medical equipment and supplies manufacturing d2c biotechnology aptamer assay technology molecular biomarkers detection biosensor assay development dna aptamer detection healthcare equipment & supplies medical device innovation chronic disease monitoring point of care diagnostics dna aptamer sequences dna aptamer design molecular diagnostics clinical laboratory alternatives phenylketonuria (pku) monitoring bluetooth-enabled device clinical test development real-time clinical quality fda breakthrough device novel test strategies small molecule detection

Location

303 College Rd E, Princeton, New Jersey, United States, 08540

Related Companies

Companies in the same industry